Logo

Wellington Management Reports 11.5 Percent Stake in Celera

May 12, 2008
NEW YORK (GenomeWeb News) – Boston-based investment advisor Wellington Management Company owns an 11.53 percent stake in Celera, according to a US Securities and Exchange Commission filing today.
 
According to the 13G/A filing, Wellington, in its capacity as an investment advisor, owns 9,094,951 shares on behalf of clients of the firm. It noted in the filing that “no such client is known to have such right of power with respect to more than five percent” of Celera’s common stock.
 
Wellington is among the top institutional holders of Celera’s common stock. According to a recent filing by Celera, Fidelity Management & Research holds a nearly 13 percent stake in the firm, while AXA Assurances IARD Mutuelle owns a 9.5 percent stake, and Capital Research Global Investors holds a share of 7.2 percent.

Breaking News
The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.